260 related articles for article (PubMed ID: 2701770)
1. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
[TBL] [Abstract][Full Text] [Related]
2. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis.
Aliaga L; Zozoya JM; Omar M; Mediavilla JD; Prieto J
Acta Gastroenterol Belg; 1995; 58(2):213-21. PubMed ID: 7571982
[TBL] [Abstract][Full Text] [Related]
3. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
Sellars L; Shore AC; Mott V; Wilkinson R
Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
[TBL] [Abstract][Full Text] [Related]
4. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA
Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
6. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites.
Wilkinson SP; Bernardi M; Smith IK; Jowett TP; Slater JD; Williams R
Gastroenterology; 1977 Oct; 73(4 Pt 1):659-63. PubMed ID: 19338
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
10. Effect of dipyridamole on kidney function in cirrhosis.
Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system.
Colantonio D; Casale R; Pasqualetti P
Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427
[TBL] [Abstract][Full Text] [Related]
12. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
[TBL] [Abstract][Full Text] [Related]
13. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
[TBL] [Abstract][Full Text] [Related]
14. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
15. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
16. The renin-angiotensin-aldosterone system in human hepatic cirrhosis.
Bernardi M; Gasbarrini G
Isr J Med Sci; 1986 Feb; 22(2):70-7. PubMed ID: 3512474
[TBL] [Abstract][Full Text] [Related]
17. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
[TBL] [Abstract][Full Text] [Related]
18. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites.
Kalambokis G; Fotopoulos A; Economou M; Pappas K; Tsianos EV
J Hepatol; 2007 Feb; 46(2):213-21. PubMed ID: 17156883
[TBL] [Abstract][Full Text] [Related]
19. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion.
La Villa G; Laffi G; Pinzani M; Pampana A; Mannelli M; Smorlesi C; Gentilini P
Boll Soc Ital Biol Sper; 1984 Mar; 60(3):535-41. PubMed ID: 6561965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]